How much funding has Moonwalk Bio raised?

Moonwalk Bio has raised $28.5M in total funding, most recently a Seed round.

Who are Moonwalk Bio's investors?

Moonwalk Bio's investors include Alpha Wave Ventures, ARCH Venture Partners, Future Ventures, GV, Khosla Ventures, YK Bioventures.

When was Moonwalk Bio founded?

Moonwalk Bio was founded in 2022.

Where is Moonwalk Bio headquartered?

Moonwalk Bio is headquartered in South San Francisco.

What industry is Moonwalk Bio in?

Moonwalk Bio operates in Biotech.

How many employees does Moonwalk Bio have?

Moonwalk Bio has 11-50 employees.

Moonwalk Bio

Moonwalk Biosciences

South San Francisco · Founded 2022 · $28.5M raised

Biotech

Headquarters: South San Francisco
Employees: 11–50
Founded: 2022
Business Model: B2B

Total Funding: $28.5M
Last Round: $28.5M SeedJan 2024
Rounds: 1

About

Moonwalk Biosciences is an epigenetic biology and AI company pioneering therapeutics in adipose biology, driven by deep genetic and epigenetic insights. The company couples an epigenetic discovery platform with precise engineering to open the epigenome as a new class of therapeutic targets, using it to identify novel targets involved in obesity and cardiometabolic disease. Co-founded by CRISPR pioneer Feng Zhang alongside Alex Aravanis, Arash Jamshidi, and Justin Valley, Moonwalk is advancing an early-stage pipeline of precision epigenetic medicines from its South San Francisco, California headquarters.

Summary

Moonwalk Bio is a Biotech company based in South San Francisco, founded in 2022. It has raised $28.5M in total across 1 round, most recently a $28.5M Seed round in Jan 2024. Investors include Alpha Wave Ventures, ARCH Venture Partners and Future Ventures.